Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.biologicals.2021.04.005 http://scihub22266oqcxt.onion/10.1016/j.biologicals.2021.04.005 33966960!8102086!33966960     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\33966960.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biologicals 2021 ; 71 (ä): 55-60 Nephropedia Template TP {{tp|p=33966960|t=2021. IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?|pdf=|usr=}}{{33966960}} gab.com Text IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time JO: Biologicals http://www.kidney.de/pget.php?&tw=1&pmid=33966960 #FOAvip The International Alliance for Biological Standardization and the Coalition for Epidemic Preparedness Innovations organized a joint webinar on the use of platform technologies for vaccine development. To tackle new emerging infectious diseases, including SARS-CoV-2, rapid response platforms, using the same basic components as a backbone, yet adaptable for use against different pathogens by inserting new genetic or protein sequences, are essential. Furthermore, it is evident that development of platform technologies needs to continue, due to the emerging variants of SARS-CoV-2. The objective of the meeting was to discuss techniques for platform manufacturing that have been used for COVID-19 vaccine development, with input from regulatory authorities on their experiences with, and expectations of, the platforms. Industry and regulators have been very successful in cooperating, having completed the whole process from development to licensing at an unprecedented speed. However, we should learn from the experiences, to be able to be even faster when a next pandemic of disease X occurs. Twit Text FOAVip IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time ????Biologicals http://www.kidney.de/pget.php?&tw=1&pmid=33966960 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33966960 #FOAvip English Wikipedia <ref>{{Cite pmid|33966960}}</ref> IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time? #MMPMID33966960 Vandeputte J; Saville M; Cavaleri M; Friede M; Hacker A; Mueller SO; Rizzi R; Smith D; Thirstrup S; Wagner R; Baay M; Neels P Biologicals 2021[Jun]; 71 (ä): 55-60 PMID33966960show ga The International Alliance for Biological Standardization and the Coalition for Epidemic Preparedness Innovations organized a joint webinar on the use of platform technologies for vaccine development. To tackle new emerging infectious diseases, including SARS-CoV-2, rapid response platforms, using the same basic components as a backbone, yet adaptable for use against different pathogens by inserting new genetic or protein sequences, are essential. Furthermore, it is evident that development of platform technologies needs to continue, due to the emerging variants of SARS-CoV-2. The objective of the meeting was to discuss techniques for platform manufacturing that have been used for COVID-19 vaccine development, with input from regulatory authorities on their experiences with, and expectations of, the platforms. Industry and regulators have been very successful in cooperating, having completed the whole process from development to licensing at an unprecedented speed. However, we should learn from the experiences, to be able to be even faster when a next pandemic of disease X occurs. |*Drug Development[MESH] |COVID-19 Vaccines/*immunology/therapeutic use[MESH] |COVID-19/*immunology/*prevention & control[MESH] |Congresses as Topic[MESH] |Humans[MESH]IABS/CEPI platform technology webinar: Is it possible to reduce the va(epmc).pdf DeepDyve Pubget Overpricing